To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
The Biotechnology Faculty has been created by grouping relevant Sections from other F1000 Faculties, it therefore does not have separate Heads of Faculty, Section Heads or Faculty Members.
This structural study by Ocasio, Corrêa and Gardner demonstrates a phosphorylation-mediated transition between unfolded and folded states for a single-domain response regulator, expanding the repertoire of regulated conformational changes within this large...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
7 Recommendations, most recent by| Interesting Hypothesis | New Finding | Novel Drug Target | Technical Advance
Past 7 Days
New Articles Recommended
Past 30 Days
76Articles Classified As New Finding26,245 total
25Articles Classified As Novel Drug Target3,243 total
1Articles Classified As Controversial1,775 total
49Articles Classified As Technical Advance11,202 total
9Articles Classified As Review / Commentary865 total
17Articles Classified As Confirmation4,616 total
27Articles Classified As Good for Teaching1,874 total
28Articles Classified As Interesting Hypothesis6,964 total
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.